Abstract | BACKGROUND/AIMS: METHODS:
Glycated hemoglobin (HbA1c) concentrations were retrospectively analyzed in patients with type 2 diabetes who were treated with tele-prescription because of COVID-19 and those who were treated by face-to-face care (non-tele-prescription group) enrolled at the same period of time. Mean HbA1c concentrations and mean change in HbA1c concentration (ΔHbA1c) were compared in these two groups. RESULTS: The mean HbA1c levels of patients were significantly higher after than before the tele-prescription period (7.46% ± 1.24% vs. 7.27% ± 1.13%, p < 0.05). Mean ΔHbA1c was significantly higher in the tele-prescription than in the non-tele-prescription group (0.19% ± 0.68% vs. 0.04% ± 0.95%, p < 0.05). HbA1c was significantly greater in patients taking fewer oral hypoglycemic agents, no insulin, fewer comorbidities (e.g., coronary artery disease, cerebrovascular accident, and diabetic neuropathy), and higher baseline HbA1c. CONCLUSION:
|
Authors | Sung-Don Park, Na-Young Kim, Jae-Han Jeon, Jung-Guk Kim, In-Kyu Lee, Keun-Gyu Park, Yeon-Kyung Choi |
Journal | The Korean journal of internal medicine
(Korean J Intern Med)
Vol. 36
Issue 4
Pg. 942-948
(07 2021)
ISSN: 2005-6648 [Electronic] Korea (South) |
PMID | 34092049
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Blood Glucose
- Glycated Hemoglobin A
- Hypoglycemic Agents
|
Topics |
- Blood Glucose
- COVID-19
- Diabetes Mellitus, Type 2
(diagnosis, drug therapy, epidemiology)
- Glycated Hemoglobin
(analysis)
- Glycemic Control
- Humans
- Hypoglycemic Agents
(therapeutic use)
- Prescriptions
- Republic of Korea
(epidemiology)
- Retrospective Studies
- SARS-CoV-2
|